TotalMarketCap

XORTX Therapeutics

XRTXNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.653 M

$0.91 -8.08%

Close of 6 Nov 2026

As of 6 Nov 2026, XORTX Therapeutics (XRTX) has a market capitalization of $1.65M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #486Propanc BiopharmaPPCB$1.72M
  2. #487GenprexGNPX$1.70M
  3. #488XORTX TherapeuticsXRTX$1.65M
  4. #489OragenicsOGEN$1.55M
  5. #490Kairos PharmaKAPA$1.55M

What if XORTX Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$15,544,105

Per share 17,081,434× higher

Bitcoin $1.53T

$841,064.43

Per share 924,247× higher

Apple $5.02T

$2,761,136

Per share 3,034,215× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for XORTX Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.